Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Medivir AB, commonly referred to as Medivir, is a Swedish-based company specialising in research and development services within the pharmaceutical industry. Headquartered in Stockholm, Sweden, Medivir operates across key regions, focusing on innovative solutions for unmet medical needs. Since its founding in 1987, the company has established a strong reputation for its expertise in antiviral and oncology research.
Medivir’s core offerings include the development of novel therapeutics and licensing collaborations, with a particular emphasis on personalised medicine. Its unique approach combines cutting-edge science with strategic partnerships, positioning Medivir as a notable player in the R&D services sector. Recognised for its scientific rigour and innovative pipeline, Medivir continues to advance its market position in the global biopharmaceutical landscape.
-12 vs industry average
MEDIVIR’s score of 21 is lower than 40% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Research Services has below-average carbon intensity
The Research Services industry has reduced its overall emissions by 19% since 2018
No reported emissions data is available for MEDIVIR yet.
MEDIVIR, a Swedish research and development services company (NAICS 541700), has not publicly disclosed its carbon emissions data. Therefore, specific details regarding its Scope 1, Scope 2, and Scope 3 emissions are unavailable. The company has not set any publicly reported carbon reduction targets, nor is it committed to initiatives like the Science Based Targets initiative (SBTi) or The Climate Pledge.
No climate goals have been disclosed for MEDIVIR yet.
No scope 3 category breakdown has been disclosed yet.


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more